Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,676Revenue $M1,070Net Margin (%)6.2Z-Score4.1
Enterprise Value $M1,826EPS $1.2Operating Margin %10.7F-Score4
P/E(ttm))25.0Cash Flow Per Share $3.7Pre-tax Margin (%)10.1Higher ROA y-yN
Price/Book2.210-y EBITDA Growth Rate %0Quick Ratio1.5Cash flow > EarningsY
Price/Sales1.65-y EBITDA Growth Rate %0Current Ratio2.1Lower Leverage y-yY
Price/Cash Flow5.5y-y EBITDA Growth Rate %-43.8ROA % (ttm)5.9Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)9.5Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M54.5ROI % (ttm)16.2Gross Margin Increase y-yN

Gurus Latest Trades with CJES

Number of guru portfolios checked: 54.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
CJESDavid Dreman 2013-12-31 Buy $20.02 - $24.36
$ 30.2532%New holding, 1715 sh.1,715
CJESJoel Greenblatt 2013-09-30 Buy 0.08%$19.11 - $21.92
$ 30.2546%New holding, 118627 sh.118,627
CJESRonald Muhlenkamp 2013-09-30 Sold Out -0.19%$19.11 - $21.92
$ 30.2546%Sold Out0
CJESRon Baron 2013-06-30 Sold Out $17.59 - $21.26
$ 30.2557%Sold Out0
CJESGeorge Soros 2013-06-30 Sold Out -0.09%$17.59 - $21.26
$ 30.2557%Sold Out0
CJESGeorge Soros 2013-03-31 Buy 0.09%$21.41 - $25.04
$ 30.2531%New holding, 325000 sh.325,000
CJESRon Baron 2013-03-31 Reduce-0.07%$21.41 - $25.04
$ 30.2531%Reduce -99.1%4,553
CJESRon Baron 2012-06-30 Reduce-0.03%$16.4 - $19.2
$ 30.2569%Reduce -33.11%503,670
CJESRon Baron 2012-03-31 Add0.02%$16.25 - $22.92
$ 30.25140%Add 25.5%753,020
CJESRonald Muhlenkamp 2011-12-31 Buy 0.44%$14.31 - $22.82
$ 30.25207%New holding, 102225 sh.102,225
CJESRon Baron 2011-09-30 Buy 0.07%$17.96 - $32.8
$ 30.2525%New holding, 600000 sh.600,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CJES is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
CJES David Dreman 2013-12-311,71500New Buy
CJES Joel Greenblatt 2013-12-31121,7630.220.07+2.64%
Premium Most recent portfolio changes are included for Premium Members only!

CJES: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MCMULLEN RANDALL C. JR.See Remarks 2014-02-18Sell30,000$24.1323.66view
MCMULLEN RANDALL C. JR.See Remarks 2014-02-18Sell30,000$21.1341.22view
MOORE THEODORE R.EVP, General Counsel 2014-02-18Sell8,455$24.2223.2view
McCoy Michael A.See Remarks 2014-02-18Sell13,334$24.223.31view
BEADLE BARRY J.President - Total E&S 2013-11-12Sell8,400$23.4827.09view
DRIVER WILLIAM D.SVP - Hydraulic Fracturing 2013-11-05Sell10,000$23.1329.01view
Wallace TimSVP - Casedhole Wireline 2013-08-13Sell2,873$20.9642.37view
MCMULLEN RANDALL C. JR.See Remarks 2013-08-06Sell20,000$21.4439.18view
DRIVER WILLIAM D.SVP - Hydraulic Fracturing 2013-08-05Sell10,000$21.1940.82view
SIMMONS BRANDON D.VP-Coiled Tubing 2013-02-26Sell15,000$23.6226.33view

Press Releases about CJES :

    Quarterly/Annual Reports about CJES:

    News about CJES:

    Articles On GuruFocus.com
    Screening with Ben Graham’s Lost Magic Formula in 1976 Jun 13 2013 
    comment on CJES Mar 18 2013 
    comment on CJES Mar 18 2013 
    PE of 5 No debt Jul 17 2012 
    greenblatt ratio Jul 07 2012 
    comment on CJES Jul 07 2012 
    comment on CJES Jun 27 2012 
    low pe hight roi May 20 2012 
    comment on CJES Apr 04 2012 
    Investor Nov 09 2011 

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial